» Articles » PMID: 11501512

The Impact of Psoriasis on Quality of Life

Overview
Journal Br J Dermatol
Specialty Dermatology
Date 2001 Aug 15
PMID 11501512
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Psoriasis is a chronic inflammatory skin disease in which the signs vary from one patient to another and over time. Traditionally, physicians have used various parameters to assess the severity of the disease: percentage of body surface area covered, erythema, plaque thickness, degree of scaling and systemic symptoms such as arthritis. However, these clinical assessments alone do not accurately reflect the overall effect of the disease on patients' daily activities. Apart from the clinical severity of affected areas, psoriasis can also have a profound psychosocial impact on the patient's quality of life. This concept is multidimensional, encompassing the physical, social and psychological wellbeing of the person and is based on the patient's view of their condition.

Citing Articles

Psychiatric Morbidities and Their Impact on Quality of Life in Patients With Psoriasis.

Kumar A, Bhuyan D, Barua S, Dihingia S, Borgohain L Cureus. 2023; 15(8):e43394.

PMID: 37706139 PMC: 10495268. DOI: 10.7759/cureus.43394.


Insights into Nutritional Strategies in Psoriasis.

Constantin C, Surcel M, Munteanu A, Neagu M Nutrients. 2023; 15(16).

PMID: 37630719 PMC: 10458768. DOI: 10.3390/nu15163528.


Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study).

Kim D, Son S, Jeong K, Ahn J, Lee E, Kim I Ann Dermatol. 2023; 35(2):107-115.

PMID: 37041704 PMC: 10112372. DOI: 10.5021/ad.22.041.


Psoriatic Foot Involvement is the Most Significant Contributor to the Inconsistency Between PASI and DLQI: A Retrospective Study from China.

Yang J, Hu K, Li X, Hu J, Tan M, Zhang M Clin Cosmet Investig Dermatol. 2023; 16:443-451.

PMID: 36815200 PMC: 9939794. DOI: 10.2147/CCID.S396997.


Female sexual dysfunction in psoriasis: a systematic review and meta-analysis using the Female Sexual Function Index.

Shah S, Merchant S, Shah S Int J Impot Res. 2022; 36(3):232-241.

PMID: 36456639 DOI: 10.1038/s41443-022-00650-9.